Table: Kissei Pharm -Q1 group results

Kissei Pharmaceutical

31/07/2023 07:00

Jul 31 (Reuters)- 
             Kissei Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2023        Jun 30, 2022     Mar 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             19.31               16.29            74.50    
                 (+18.6 pct)         (-2.1 pct)       (+10.4 pct) 
  Operating          1.63              130 mln            4.20    
                                     (-55.4 pct)                  
  Recurring          2.71              806 mln            5.20    
                (+236.2 pct)         (+5.6 pct)      (+768.4 pct) 
  Net                3.27                1.64            10.60    
                 (+99.6 pct)         (-55.1 pct)      (+0.7 pct)  
  EPS             70.95 yen           35.47 yen       229.86 yen  
  Ann Div                             80.00 yen        82.00 yen  
  -Q2 div                             40.00 yen        41.00 yen  
  -Q4 div                             40.00 yen        41.00 yen  
  
  NOTE - Kissei Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4547.T